Objective: Bronchoscopy and bronchoalveolar lavage are common procedures in intensive care units, however no contemporaneous safety and outcomes data have been reported, particularly for critically ill patients.
INTRODUCTION
Bronchoscopy and bronchoalveolar lavage (BAL) are common procedures in intensive care units; however, the safety and complication rates in mechanically-ventilated patients have not been reported since the early 1990's. Since that time, research in critically ill patients has increased and therefore more procedures are done for the sole purpose of clinical and translational research.
Earlier studies addressing the safety of bronchoscopy included patients who underwent bronchoscopy with BAL and protected-specimen brush for diagnostic purposes, or a combined patient population who had a procedure for either diagnostic or research purposes [1] [2] [3] . The complications reported included significant hypoxemia, cardiac arrhythmias, hypotension, bleeding and pneumothorax. In these studies, hypoxemia was reported as SaO 2 <90% and hypotension as mean arterial pressure <60 mm Hg. The rates of these complications or adverse events ranged from 2% to 40% [1 -5] . All of these studies concluded that while bronchoscopy with BAL is usually well tolerated in critically ill patients, attention to procedural safety and guidelines are imperative [1, 2] .
Given the non-contemporaneous nature of informative studies, we aimed to examine the safety of bronchoscopy for research purposes in critically ill, mechanically ventilated patients in current intensive care unit (ICU) settings.
METHODS

Sites and Patient Selection:
Patients were screened daily for the presence of severe sepsis and/or or acute lung injury (ALI), and then enrolled into one or more clinical studies that required performing a bronchoscopy. Specifically, one study was an observational study of
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4 patients with severe sepsis or septic shock [6] and the other study was a randomized control trial of albumin vs. hetastarch in patients with acute respiratory distress syndrome (ARDS) [7] . 
RESULTS
Characteristics of Patient Population
One-hundred bronchoscopies with BAL were performed on critically ill patients for research purposes. Men comprised 51% of the patients; 81% of patients were black, 15% were white, and 4% were of other ethnicities ( Table 1) . The mean age of the cohort was 52 (SD16) years. ALI was present in 67% of this population and severe sepsis was present in 91%. The mean APACHE score was 22 (SD 7.5) while the median day 1 SOFA score was 9 (IQR 5-12).
Hospital mortality for the cohort was 38%. The median PaO 2 to FIO 2 ratio was 218 (IQR 146-
). The average amount of lavage fluid instilled was 188 mL, with an average return of 79 mL. 
Types of Complications
Characteristics of patients stratified by the presence of complications
Females comprised 80% of the patients with complications ( Table 2 ). The mean age was 41 years (SD 11) and all of the patients were black. The mean APACHE score was 20 (SD 7.5)
with a median SOFA of 6 (IQR 0-11 In the group of patients who did not experience complications related to bronchoscopy with BAL, 55% of the patients were male, the mean age was 54 (SD16) years and 78% were black. The mean APACHE score was 22 (SD7.6) and median SOFA was 9 (IQR 7-12). . The median PaO 2 to FIO 2 was 228 (IQR 146-313). The hospital mortality in this group was 41%.
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In comparing patients with and without complications, the complications group was comprised of a majority of females, 80% vs. 45%, p = 0.04. ( Table 2) . Patients with complications from bronchoscopy with BAL were significantly younger than patients without complications (41 years vs. 54 years, p = 0.01). There was no difference in the presence of shock or ALI between patients with and without complications. PaO 2 /FIO 2 was not associated with complications, while there was a trend towards increased complications in patients requiring higher levels of PEEP (p=0.097). Mortality was higher in the group without complications compared to those with complications (41% vs. 10%, p=0.06), although not statistically significant. There was no difference in hospital length of stay or ventilator free days between patients with and without complications.
DISCUSSION
Bronchoscopy with BAL is a common procedure in the ICU utilized for both clinical and research purposes. As more research on critically ill patients is conducted, more research bronchoscopies will be performed in this group of patients. This study is the first to systematically review the performance and safety of bronchoscopy specifically for research purposes in critically ill patients, specifically in patients with severe sepsis or ARDS. In our cohort, 100 bronchoscopies were performed on critically ill patients with severe sepsis, ALI or both, and resulted in a complication rate of 10%. This was mostly attributed to clinically significant hypoxemia in 6% of patients, and with 1 instance each of bradycardia and hypotension.
Hertz et al [1] examined ninety-nine critically ill, mechanically ventilated patients who
underwent bronchoscopy with BAL for diagnostic purposes. They reported that none of their
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Another study from Steinberg [3] was conducted on 110 critically ill, mechanically bronchoscopy may be associated with adverse events, these two studies indicate that research bronchoscopy in patients with COPD and asthma is well tolerated and is not associated with significant adverse events that require specific intervention or prolonged morbidity.
When comparing patients with and without complications in our current study, we found both younger age and female gender to be associated with complications. The reason for this finding is unclear. Gender and age have not been previously reported as significant risk factors for bronchoscopy. In fact, bronchoscopy has been shown to be well tolerated in both the elderly and the young [13] . The sample size of our study may explain these findings. Furthermore, all the patients with complications were black which is not surprising since the majority of the study population were black. It is unlikely that race alone is a risk factor for bronchoscopy complications.
The strength of this study is its systematic reporting of bronchoscopy-related complications in a contemporaneous and specifically-defined population of critically ill patients with sepsis and ALI. Importantly, with these data the patients and their surrogates providing and only 1 episode resulted in premature termination of the procedure. The duration of desaturation was not recorded for mild episodes of hypoxemia, which were managed by the primary ICU team. This is a potential weakness of our study.
The primary limitation of this study is the sample size, which is limited by the frequency of research bronchoscopy in critically ill patients even in a large multi-institutional study. A larger sample size would permit more confidence in the reported complications, and potentially permit the capture of rare complications not seen in this study. Also, despite the inherent flaws of retrospective analyses, it should be noted that the data for this study were collected prospectively.
CONCLUSION
Bronchoscopy with BAL in critically ill patients with sepsis and ALI is well tolerated with a 10% complication rate primarily related to transient hypoxemia. Furthermore, 1% of procedures may require premature termination due to complications. Age, female gender and higher PEEP were associated with complications, which were not associated with longer duration of ventilation, hospital stay or mortality. These data are useful as a current examination of the safety of bronchoscopy in a large population of critically ill patients, to optimally inform the consent process for subjects and their surrogates. Table 2 . 
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